Anisa Mohanty advises life sciences companies on regulatory, compliance, enforcement, policy, and legislative matters arising under the Federal Food, Drug, and Cosmetic Act (FDCA). She counsels pharmaceutical, medical device, and consumer product companies on premarket pathways, advertising and promotion, and current Good Manufacturing Practice (cGMP) and Quality System requirements. Anisa also assists clients with US Food and Drug Administration (FDA) engagement strategies and responding to FDA administrative and enforcement actions. She advises companies and investors on regulatory and compliance issues arising from mergers, acquisitions, and other transactions involving FDA-regulated products as well as issues related to disclosure and periodic reporting.

Show More


  • Food and Drug Administration Alumni Association, Finance Committee, Membership Recruitment Committee member
  • District of Columbia Bar, Health Law Section, member
  • The American Health Lawyers Association, member
  • Food and Drug Law Institute, member


University of Richmond School of Law, JD, 2010
University of North Carolina at Chapel Hill, BA, 2007

District of Columbia
North Carolina

Anisa Mohanty

Insights & Events / Media

Special Report / January 7, 2019

Boston, Massachusetts / Speaking Engagements / October 17, 2018

On the Subject / June 15, 2018

AHLA (American Health Lawyers Association) / March 2018

Special Report / January 11, 2018

A Practical Guide to FDA’s Food and Drug Law and Regulation / September 2017

Food and Drug Law Institute / August 2017

Special Report / February 8, 2017